U.S. Insurance Stock News

NasdaqGS:IOSP
NasdaqGS:IOSPChemicals

Is It Time To Reassess Innospec (IOSP) After Its Recent Share Price Slide

Wondering whether Innospec's current share price still reflects its underlying worth, or if the market is mispricing it, is a fair question for anyone tracking specialty chemicals stocks. Over the past week the stock has recorded a 8.8% decline, with a 2.3% decline over 30 days, a 3.5% gain year to date, and a 20.9% decline over one year, while the three and five year returns stand at 25.8% and 16.4% declines respectively. These moves have kept Innospec on the radar of investors who are...
NYSE:CRH
NYSE:CRHBasic Materials

CRH Ramps Up Deals And Eyes U.S. Infrastructure Opportunity

CRH (NYSE:CRH) completed more than three dozen acquisitions in 2025. The company acquired Eco Material Technologies, described as a transformative deal for its portfolio. Management is preparing for expected strength in U.S. infrastructure spending in 2026, including state and federal highway projects. CRH, a major player in construction materials and solutions, is using acquisitions to build out its U.S. footprint and broaden its mix of products and services. The Eco Material Technologies...
NasdaqGS:CIFR
NasdaqGS:CIFRSoftware

Assessing Cipher Mining (CIFR) Valuation As Quarterly Earnings Approach

Why Cipher Mining is back on investor radar Cipher Mining (CIFR) is drawing attention ahead of its upcoming quarterly earnings, as traders watch how results and any commentary on future operations might influence sentiment around the data center focused miner. See our latest analysis for Cipher Mining. The upcoming earnings announcement and the recent appointment of real estate specialist Thomas Duda to the board come after a mixed stretch, with a 3.89% 1 day share price return but a 13.38%...
NasdaqCM:CAPR
NasdaqCM:CAPRBiotechs

Capricor Therapeutics (CAPR) Deepens Its Exosome Bet: Strategic Edge or Concentration Risk?

Capricor Therapeutics recently advanced its lead candidate Deramiocel into phase 3 trials for Duchenne muscular dystrophy while progressing preclinical work on its exosome-based SARS-CoV-2 vaccine and StealthX exosome platform. This pipeline momentum, coupled with unanimous positive analyst coverage, highlights how central Deramiocel and exosome technologies have become to the company’s long-term thesis. Next, we’ll examine how Deramiocel’s phase 3 progress and upbeat analyst sentiment feed...
NYSE:NEM
NYSE:NEMMetals and Mining

A Look At Newmont (NEM) Valuation After Earnings Beat Dividend Hike And Cautious 2026 Guidance

Newmont (NEM) is back in focus after reporting Q4 and full year 2025 results that beat analyst earnings and revenue expectations. The company also announced a 4% dividend increase and provided cautious 2026 production and cost guidance. See our latest analysis for Newmont. Newmont’s latest Q4 beat and dividend hike come after a sharp share price move, with a 90 day share price return of 44.02% and a 1 year total shareholder return of 186.91%. This suggests momentum has strengthened even as...
NYSE:CMG
NYSE:CMGHospitality

Global Tariffs Put Chipotle Supply Chains And Margin Resilience Under Scrutiny

The Trump administration has reimposed 15% global tariffs under the Trade Act of 1974. Chipotle Mexican Grill (NYSE:CMG) faces potential disruption and higher costs across its international supply chains. The new tariffs introduce fresh uncertainty for sourcing key ingredients and supporting cross border operations. For Chipotle Mexican Grill, with shares last closing at $36.61, the tariff backdrop lands at a time when recent returns have been mixed. The stock is up 0.9% over the past week,...
NasdaqGS:TROW
NasdaqGS:TROWCapital Markets

Assessing T. Rowe Price (TROW) Valuation After Recent Share Price Weakness

T. Rowe Price Group (TROW) has attracted fresh attention after recent share price weakness, with the stock showing negative returns over the month and past 3 months. This has prompted investors to reassess its current valuation and fundamentals. See our latest analysis for T. Rowe Price Group. At a share price of $93.06, T. Rowe Price Group has seen a 1 day share price return of 2.43% decline and a 30 day share price return of 11.90% decline, while its 1 year total shareholder return of 8.04%...
NYSEAM:BMNR
NYSEAM:BMNRSoftware

Bitmine Immersion Deepens Ethereum Bet As MAVAN And Institutions Gather

Bitmine Immersion Technologies (NYSEAM:BMNR) now controls more than 3.6% of all Ethereum as it builds out a large ETH position. The company is preparing to launch its MAVAN staking infrastructure, focused on Ethereum staking at scale. Major institutional investors have recently increased their positions in BMNR, pointing to growing interest in its Ethereum-centric approach. Bitmine Immersion Technologies, trading at $19.22, has experienced mixed returns, with the share price up 163.4% over...
NYSE:BF.B
NYSE:BF.BBeverage

Is There Now An Opportunity In Brown‑Forman (BF.B) After Multi‑Year Share Price Weakness

If you are wondering whether Brown-Forman is fairly priced or offering value right now, this article walks through the key numbers that matter. The share price closed at US$30.20 most recently, with returns of 0.8% over 7 days, 9.5% over 30 days and 15.5% year to date, compared with a 5.2% decline over 1 year, a 50.8% decline over 3 years and a 54.3% decline over 5 years. Recent coverage of Brown-Forman has focused on how the spirits group is positioned in the branded alcohol market and how...
NYSE:TX
NYSE:TXMetals and Mining

Is It Time To Reassess Ternium (NYSE:TX) After A 59% One Year Share Price Gain

If you are wondering whether Ternium's current share price gives you good value, this article walks through what the numbers actually say and how that lines up with different valuation methods. Ternium's stock closed at US$43.33, with a 1 year return of 59.4% and a 5 year return of 96.2%. This comes even though the shares show a 0.7% decline over 7 days, a 1.1% decline over 30 days, and a 10.7% gain year to date. Recent coverage has put a spotlight on how investors are weighing steel demand,...
NYSE:THC
NYSE:THCHealthcare

Is It Time To Reassess Tenet Healthcare (THC) After Its 3 Year Share Price Surge?

If you are wondering whether Tenet Healthcare's current share price lines up with its underlying value, this article is designed to walk you through that question step by step. Tenet Healthcare's stock last closed at US$233.77, with returns of 1.2% over 7 days, 23.8% over 30 days, 17.2% year to date, 77.7% over 1 year and 299.3% over 3 years. These figures can change how investors think about both upside and risk. Recent news around Tenet Healthcare has focused on its role in the US hospital...
NYSE:MANU
NYSE:MANUEntertainment

Is Manchester United (MANU) Pricing Reflect Future Ownership Shifts Or Recent Steady Share Performance

With Manchester United stock trading at around US$17.40, this article considers whether that price represents a bargain or reflects the club's famous name, and explores what the current market valuation might be implying about the club's overall worth. The share price has been relatively steady in the very short term, with a 0.2% decline over the last 7 days, a 1.3% gain over 30 days, and returns of 10.3% year to date and 18.0% over the past year, compared with weaker figures over 3 and 5...
NYSE:BXP
NYSE:BXPOffice REITs

A Look At Boston Properties (BXP) Valuation After Recent Weak Share Performance

BXP stock performance and recent context BXP (BXP) has attracted investor attention after a period of weaker share performance, with the stock showing negative returns over the past week, month, past 3 months, year to date, and past year. See our latest analysis for BXP. At a share price of $59.62, BXP has seen momentum cool recently, with short term share price returns weaker than earlier periods and the 1 year total shareholder return of a 9.1% decline contrasting with a 3 year total...
NYSE:DLR
NYSE:DLRSpecialized REITs

Is It Time To Reassess Digital Realty Trust (DLR) After Strong Data Center Growth Hopes

If you are wondering whether Digital Realty Trust is reasonably priced at today's levels, it helps to first anchor what the recent share moves and fundamentals might be telling you about value. The stock most recently closed at US$176.09, with a 7 day return of a 2.7% decline, a 30 day return of 10.6%, a year to date return of 13.6%, a 1 year return of 13.7%, a 3 year return of 86.1% and a 5 year return of 57.5%. Recent news around Digital Realty Trust has focused on its role as a major data...
NYSE:TEVA
NYSE:TEVAPharmaceuticals

Has Teva (TEVA) Run Too Far After Its 102% One-Year Share Price Surge?

If you are wondering whether Teva Pharmaceutical Industries is still good value after its recent run, this article walks through what the current share price might be implying about the company. Teva's share price last closed at US$33.91, with returns of 6.6% over the past 30 days, 9.6% year to date and 102.1% over the last year. The 3 year and 5 year returns sit at 242.5% and 210.5% respectively, which raises the question of how much optimism is already reflected in the price. Recent...
NYSE:AMC
NYSE:AMCEntertainment

AMC Entertainment Holdings (AMC) Posts Q4 Loss That Challenges Bullish Margin Narratives

AMC Entertainment Holdings (AMC) just posted its FY 2025 numbers with Q4 revenue of US$1,288.3 million, a basic EPS loss of US$0.25, and net income excluding extra items showing a loss of US$127.4 million, while trailing 12 month figures sit at US$4.8 billion of revenue, a basic EPS loss of US$1.34, and a net loss of US$632.4 million. Over recent quarters, the company has seen quarterly revenue move from US$862.5 million in Q1 2025 to between roughly US$1.3 billion and US$1.4 billion through...
NYSE:HASI
NYSE:HASIDiversified Financial

A Look At HA Sustainable Infrastructure Capital’s Valuation After Recent Green Bond Issues And 2025 Earnings Results

Funding moves and earnings set the stage for HASI HA Sustainable Infrastructure Capital (HASI) has just completed two green bond offerings totaling about US$1.0b, alongside releasing its fourth quarter and full year 2025 results. This combination gives investors fresh information on both funding and profitability. See our latest analysis for HA Sustainable Infrastructure Capital. The recent green bond issues and earnings update come after a 30 day share price return of 10.63% and a year to...
NYSE:DINO
NYSE:DINOOil and Gas

Is HF Sinclair (DINO) Still Attractive After Recent Share Price Volatility?

If you are wondering whether HF Sinclair is still good value after its recent run, or if the price already reflects most of the story, this article will walk you through what the current share price could be implying. The stock recently closed at US$49.59, with a 7 day return of 15.3% decline, a 30 day return of 0.8% decline, a 1 year return of 41.1% and a 5 year return of 50.6%. These moves sit against a backdrop of ongoing interest in US energy stocks, where investors have been weighing...
NYSE:PFS
NYSE:PFSBanks

Is Provident Financial Services (PFS) Attractively Priced After Recent Regional Banking Sector Concerns?

If you are wondering whether Provident Financial Services is offering fair value at around US$21.93 per share, you are not alone. This article will walk through what that price really implies. The stock has seen mixed returns recently, with a 4.5% decline over the last 7 days, a 6.5% gain over the last 30 days, 11.0% year to date, and 29.8% over the past year, while the 3 year and 5 year returns sit at 9.9% and 36.1% respectively. Recent news flow around regional banks and funding conditions...
NYSE:OXY
NYSE:OXYOil and Gas

Occidental Petroleum (OXY) Is Up 13.8% After Dividend Hike And Debt Tender – What's Changed

Occidental Petroleum recently reported Q4 2025 results showing revenue of US$5,423 million and net income of US$126 million, alongside a quarterly dividend increase to US$0.26 per share and new cash tender offers targeting up to US$700 million of senior notes and debentures. By pairing an earnings beat and record production with higher dividends and further debt reduction after the OxyChem sale, Occidental is signaling a clear focus on strengthening its balance sheet while increasing cash...
NasdaqGS:ADEA
NasdaqGS:ADEASoftware

A Look At Adeia (ADEA) Valuation After Recent Share Price Momentum And Mixed Market Signals

Adeia (ADEA) has drawn attention after recent trading left the stock about 4% lower over the month but roughly 50% higher in the past 3 months, prompting closer inspection of its fundamentals. See our latest analysis for Adeia. At a share price of $18.48, Adeia has given up some ground in the past month with a 30 day share price return of a 4.35% decline, but its 90 day share price return of 49.64% alongside a 3 year total shareholder return of 99.64% suggests momentum has been building over...
NYSE:EIX
NYSE:EIXElectric Utilities

Edison International Wildfire Program Highlights Valuation Risks And Cash Flow Pressures

Edison International (NYSE:EIX) has introduced a Wildfire Recovery Compensation Program for Eaton Fire victims. The program aims to provide compensation to tens of thousands of affected residents and businesses. The announcement comes as the company continues to face wildfire related legal and financial liabilities. Edison International, the parent company of Southern California Edison, operates as a regulated electric utility and is closely tied to wildfire risk across its service...
NYSE:SWK
NYSE:SWKMachinery

Stanley Black & Decker (SWK) Valuation Check After Recent Share Price Volatility

Recent performance snapshot for Stanley Black & Decker Stanley Black & Decker (SWK) has been on many investors’ radars after a mixed stretch for the shares, with a 1 day decline of 5.1% but gains over the month and past 3 months. See our latest analysis for Stanley Black & Decker. Looking past the latest 5.1% one day share price decline to US$87.29, Stanley Black & Decker’s 30 day share price return of 5.83% and 90 day gain of 23.41% contrast with a 5 year total shareholder return of 43.04%...
NYSE:CTS
NYSE:CTSElectronic

Can CTS (CTS) Sustain Its Capital Returns While Pursuing an Acquisition-Driven Strategy?

CTS Corporation recently reported past full-year 2025 results showing higher sales and net income than the prior year, reaffirmed 2026 sales guidance of US$550 million–US$580 million, and declared a US$0.04 per-share cash dividend payable on April 24, 2026 to shareholders of record on March 27, 2025. Alongside these results, CTS highlighted strong cash generation, active share repurchases, and an intention to pursue acquisitions while continuing to return cash to shareholders. Next, we'll...